• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型 1,3,4-噁二唑衍生物的分子对接、计算和抗血栓形成研究。

Molecular Docking, Computational, and Antithrombotic Studies of Novel 1,3,4-Oxadiazole Derivatives.

机构信息

Institute of Chemistry, University of the Punjab, New Campus, Lahore 54590, Pakistan.

Laboratory of Organometallics, Catalysis and Ordered Materials, State Key Laboratory of Advanced Technology for Material Synthesis and Processing, Wuhan University of Technology, Wuhan 430070, China.

出版信息

Int J Mol Sci. 2018 Nov 15;19(11):3606. doi: 10.3390/ijms19113606.

DOI:10.3390/ijms19113606
PMID:30445728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6274789/
Abstract

A new series of 1,3,4-oxadiazoles derivatives was synthesized, characterized, and evaluated for their in vitro and in vivo anti-thrombotic activity. Compounds (⁻) exhibited significant clot lysis with respect to reference drug streptokinase (30,000 IU), and enhanced clotting time (CT) values (130⁻342 s) than heparin (110 s). High affinity towards 1NFY with greater docking score was observed for the compounds (, , , , and ) than the control ligand RPR200095. In addition, impressive inhibitory potential against factor Xa (F-Xa) was observed with higher docking scores (5612⁻6270) with Atomic Contact Energy (ACE) values (-189.68 to -352.28 kcal/mol) than the control ligand RPR200095 (Docking score 5192; ACE -197.81 kcal/mol). In vitro, in vivo, and in silico results proposed that these newly synthesized compounds might be used as anticoagulant agents.

摘要

合成了一系列新的 1,3,4-噁二唑衍生物，并对其进行了表征和体外及体内抗血栓活性评价。与参比药物链激酶（30000IU）相比，化合物（⁻）显示出显著的血凝块溶解作用，与肝素（110s）相比，其凝固时间（CT）值（130-342s）延长。与对照配体 RPR200095 相比，化合物（、、、、和）对 1NFY 的亲和力更高，对接评分也更高。此外，与对照配体 RPR200095 相比（对接评分 5192；ACE-197.81kcal/mol），这些化合物对因子 Xa（F-Xa）表现出显著的抑制作用，对接评分更高（5612-6270），原子接触能（ACE）值也更高（-189.68 至-352.28kcal/mol）。体外、体内和计算结果表明，这些新合成的化合物可能可用作抗凝剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/a38b78843fe9/ijms-19-03606-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/fc8462707b6b/ijms-19-03606-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/63ca2a441c2e/ijms-19-03606-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/e4642ec8d8a5/ijms-19-03606-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/ddec10265afa/ijms-19-03606-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/8ee6fd0ce07f/ijms-19-03606-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/e995f7252b5d/ijms-19-03606-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/51e5240601ef/ijms-19-03606-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/a38b78843fe9/ijms-19-03606-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/fc8462707b6b/ijms-19-03606-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/63ca2a441c2e/ijms-19-03606-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/e4642ec8d8a5/ijms-19-03606-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/ddec10265afa/ijms-19-03606-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/8ee6fd0ce07f/ijms-19-03606-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/e995f7252b5d/ijms-19-03606-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/51e5240601ef/ijms-19-03606-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ee/6274789/a38b78843fe9/ijms-19-03606-g007a.jpg

相似文献

1
Molecular Docking, Computational, and Antithrombotic Studies of Novel 1,3,4-Oxadiazole Derivatives.新型 1,3,4-噁二唑衍生物的分子对接、计算和抗血栓形成研究。
Int J Mol Sci. 2018 Nov 15;19(11):3606. doi: 10.3390/ijms19113606.
2
New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking.新型 6-取代香豆素衍生物作为有效因子 Xa 抑制剂的研究：合成、体内抗血栓评价及分子对接。
Bioorg Chem. 2014 Feb;52:31-43. doi: 10.1016/j.bioorg.2013.11.002. Epub 2013 Nov 20.
3
Synthesis, characterization, antibacterial, hemolytic and thrombolytic activity evaluation of 5-(3-chlorophenyl)-2-((N-(substituted)-2-acetamoyl)sulfanyl)-1,3,4-oxadiazole derivatives.5-(3-氯苯基)-2-((N-(取代)-2-乙酰基硫基)-1,3,4-恶二唑衍生物的合成、表征、抗菌、溶血和溶栓活性评价。
Pak J Pharm Sci. 2020 Mar;33(2(Supplementary)):871-876.
4
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.一些新型吲哚和吡啶基1,3,4-恶二唑衍生物作为潜在抗结核药物的合成、生物学评价及分子对接研究
Bioorg Med Chem Lett. 2016 Apr 1;26(7):1776-83. doi: 10.1016/j.bmcl.2016.02.043. Epub 2016 Feb 16.
5
Exploring the Biological Activity of a Library of 1,2,5-Oxadiazole Derivatives Endowed With Antiproliferative Activity.探索具有抗增殖活性的1,2,5-恶二唑衍生物文库的生物活性。
Anticancer Res. 2019 Jan;39(1):135-144. doi: 10.21873/anticanres.13089.
6
Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.新型 1,3,4-噁二唑-2-硫酮衍生物的合成、胸苷磷酸化酶抑制活性及作为潜在抗癌剂的计算研究。
Comput Biol Chem. 2018 Oct;76:151-160. doi: 10.1016/j.compbiolchem.2018.05.013. Epub 2018 May 16.
7
Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.新型合成类肝素对大鼠体内外全血凝血酶生成的影响。
Thromb Haemost. 2002 Feb;87(2):238-44.
8
Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.新型恶二唑衍生物的合成与生物学评价：一类新型胸苷磷酸化酶抑制剂作为潜在的抗肿瘤药物
Bioorg Med Chem. 2014 Feb 1;22(3):1008-15. doi: 10.1016/j.bmc.2013.12.043. Epub 2013 Dec 30.
9
Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.采用基于配体和基于结构的联合方法，剖析代表性因子 Xa 和凝血酶抑制剂的选择性结构决定因素。
J Chem Inf Model. 2011 Aug 22;51(8):1966-85. doi: 10.1021/ci200185q. Epub 2011 Aug 1.
10
Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.新型合成因子Xa抑制剂YM-60828在大鼠血栓形成模型中的抗血栓作用及其对出血时间的影响。
Br J Pharmacol. 1998 Jan;123(1):92-6. doi: 10.1038/sj.bjp.0701566.

引用本文的文献

1
Exploring theophylline-1,2,4-triazole tethered -phenylacetamide derivatives as antimicrobial agents: unraveling mechanisms via structure-activity relationship, validation, and insights.探索茶碱-1,2,4-三唑连接的苯乙酰胺衍生物作为抗菌剂：通过构效关系、验证和深入分析揭示作用机制
Front Chem. 2024 Apr 5;12:1372378. doi: 10.3389/fchem.2024.1372378. eCollection 2024.
2
A Combined Experimental and Computational Study of Novel Benzotriazinone Carboxamides as Alpha-Glucosidase Inhibitors.新型苯并三嗪酮羧酰胺作为α-葡萄糖苷酶抑制剂的实验与计算联合研究
Molecules. 2023 Sep 14;28(18):6623. doi: 10.3390/molecules28186623.
3

本文引用的文献

1
Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis.纳豆激酶在角叉菜胶诱导的大鼠血栓形成模型中的体内溶栓作用。
Acta Haematol. 2014;132(2):247-53. doi: 10.1159/000360360.
2
Medium optimization for the production of fibrinolytic enzyme by Paenibacillus sp. IND8 using response surface methodology.利用响应面法对解淀粉芽孢杆菌IND8产纤溶酶的培养基进行优化。
ScientificWorldJournal. 2014 Jan 9;2014:276942. doi: 10.1155/2014/276942. eCollection 2014.
3
New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking.
-Arylacetamide derivatives of methyl 1,2-benzothiazine-3-carboxylate as potential drug candidates for urease inhibition.
1,2-苯并噻嗪-3-羧酸甲酯的芳基乙酰胺衍生物作为潜在的脲酶抑制候选药物。
R Soc Open Sci. 2023 Apr 5;10(4):230104. doi: 10.1098/rsos.230104. eCollection 2023 Apr.
4
Repositioning of acefylline as anti-cancer drug: Synthesis, anticancer and computational studies of azomethines derived from acefylline tethered 4-amino-3-mercapto-1,2,4-triazole.将醋茶碱重新定位为抗癌药物：醋茶碱连接 4-氨基-3-巯基-1,2,4-三唑的亚胺的合成、抗癌和计算研究。
PLoS One. 2022 Dec 15;17(12):e0278027. doi: 10.1371/journal.pone.0278027. eCollection 2022.
5
Ultrasound-Assisted Synthesis and In Silico Modeling of Methanesulfonyl-Piperazine-Based Dithiocarbamates as Potential Anticancer, Thrombolytic, and Hemolytic Structural Motifs.超声辅助合成及基于甲磺酰基哌嗪的二硫代氨基甲酸盐的计算机模拟作为有潜力的抗癌、溶栓和溶血结构基序。
Molecules. 2022 Jul 26;27(15):4776. doi: 10.3390/molecules27154776.
6
Exploring the Synergistic Anticancer Potential of Benzofuran-Oxadiazoles and Triazoles: Improved Ultrasound- and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules.探索苯并呋喃-恶二唑和三唑的协同抗癌潜力：基于呋喃的分子的超声和微波辅助合成的改进、分子对接、溶血、溶栓和抗癌评估。
Molecules. 2022 Feb 2;27(3):1023. doi: 10.3390/molecules27031023.
7
, Molecular Docking and Antimicrobial Activity of the Major Rapeseed Seed Storage Proteins.油菜籽主要种子贮藏蛋白的分子对接与抗菌活性
Front Pharmacol. 2020 Sep 8;11:1340. doi: 10.3389/fphar.2020.01340. eCollection 2020.
新型 6-取代香豆素衍生物作为有效因子 Xa 抑制剂的研究：合成、体内抗血栓评价及分子对接。
Bioorg Chem. 2014 Feb;52:31-43. doi: 10.1016/j.bioorg.2013.11.002. Epub 2013 Nov 20.
4
Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.合成具有噁二唑核的苯并咪唑类化合物作为抗癌剂。
Eur J Med Chem. 2012 Aug;54:855-66. doi: 10.1016/j.ejmech.2012.04.027. Epub 2012 May 9.
5
Novel stents for the prevention of restenosis.新型支架预防再狭窄。
Trends Cardiovasc Med. 1997 Oct;7(7):245-9. doi: 10.1016/S1050-1738(97)00066-2.
6
Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate.发现一种因子 Xa 抑制剂(3R,4R)-1-(2,2-二氟乙基)-吡咯烷-3,4-二羧酸 3-[(5-氯-吡啶-2-基)-酰胺]-4-[[2-氟-4-(2-氧代-2H-吡啶-1-基)-苯基]-酰胺]，作为一种临床候选药物。
Bioorg Med Chem Lett. 2010 Sep 1;20(17):5313-9. doi: 10.1016/j.bmcl.2010.06.126. Epub 2010 Jul 1.
7
Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit.基于筛选所得活性化合物设计新型氨基吡咯烷因子Xa抑制剂
Eur J Med Chem. 2009 Jul;44(7):2787-95. doi: 10.1016/j.ejmech.2008.12.025. Epub 2009 Jan 3.
8
Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis.阿拉伯法贡（达马萨）对体外溶栓的作用。
BMC Complement Altern Med. 2007 Nov 6;7:36. doi: 10.1186/1472-6882-7-36.
9
Development of an in vitro model to study clot lysis activity of thrombolytic drugs.用于研究溶栓药物凝块溶解活性的体外模型的开发。
Thromb J. 2006 Sep 12;4:14. doi: 10.1186/1477-9560-4-14.
10
Purification and characterization of a fibrinolytic enzyme of Bacillus subtilis DC33, isolated from Chinese traditional Douchi.从中国传统豆豉中分离的枯草芽孢杆菌DC33纤溶酶的纯化与特性研究
J Ind Microbiol Biotechnol. 2006 Sep;33(9):750-8. doi: 10.1007/s10295-006-0111-6. Epub 2006 Mar 31.